Lawsuit claims Novo Nordisk delayed generic Victoza using patent tactics and settlements, preserving monopoly pricing and ...

Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...

Lawsuits continue against makers of GLP-1 weight-loss drugs over side effects ranging from extreme vomiting to what some ...

Patients know about nausea and vomiting. Now, lawsuits are raising concerns about vision loss.

Association driven by fewer major amputations ...

Lawsuit alleges a 2019 settlement delayed Teva's generic Victoza launch, with plaintiffs seeking unspecified monetary damages ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes. These treatments can positively affect appetite, ...

Patients with a heart failure history and preserved ejection fraction appeared to benefit ...

Novo Nordisk faces a class action lawsuit for allegedly monopolizing its diabetes drug Victoza through patent misuse and ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.